Annual Revenue:
$491.73M+$93.53M(+23.49%)Summary
- As of today, CPRX annual revenue is $491.73 million, with the most recent change of +$93.53 million (+23.49%) on December 31, 2024.
 - During the last 3 years, CPRX annual revenue has risen by +$350.90 million (+249.16%).
 - CPRX annual revenue is now at all-time high.
 
Performance
CPRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Revenue:
$146.56M+$5.14M(+3.64%)Summary
- As of today, CPRX quarterly revenue is $146.56 million, with the most recent change of +$5.14 million (+3.64%) on June 30, 2025.
 - Over the past year, CPRX quarterly revenue has increased by +$23.85 million (+19.44%).
 - CPRX quarterly revenue is now at all-time high.
 
Performance
CPRX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Revenue:
$558.50M+$23.85M(+4.46%)Summary
- As of today, CPRX TTM revenue is $558.50 million, with the most recent change of +$23.85 million (+4.46%) on June 30, 2025.
 - Over the past year, CPRX TTM revenue has increased by +$124.02 million (+28.55%).
 - CPRX TTM revenue is now at all-time high.
 
Performance
CPRX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CPRX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM | 
|---|---|---|---|
| 1Y1 Year | +23.5% | +19.4% | +28.6% | 
| 3Y3 Years | +249.2% | +175.9% | +227.6% | 
| 5Y5 Years | +380.6% | +395.1% | +372.6% | 
CPRX Revenue Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +249.2% | at high | +156.0% | at high | +191.3% | 
| 5Y | 5-Year | at high | +380.6% | at high | +399.9% | at high | +372.6% | 
| All-Time | All-Time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% | 
CPRX Revenue History
| Date | Annual | Quarterly | TTM | 
|---|---|---|---|
| Jun 2025 | -  | $146.56M(+3.6%)  | $558.50M(+4.5%)  | 
| Mar 2025 | -  | $141.42M(-0.3%)  | $534.65M(+8.7%)  | 
| Dec 2024 | $491.73M(+23.5%)  | $141.82M(+10.2%)  | $491.73M(+6.8%)  | 
| Sep 2024 | -  | $128.69M(+4.9%)  | $460.48M(+6.0%)  | 
| Jun 2024 | -  | $122.71M(+24.6%)  | $434.48M(+5.6%)  | 
| Mar 2024 | -  | $98.51M(-10.9%)  | $411.35M(+3.3%)  | 
| Dec 2023 | $398.20M(+85.9%)  | $110.57M(+7.7%)  | $398.20M(+14.3%)  | 
| Sep 2023 | -  | $102.69M(+3.1%)  | $348.39M(+15.0%)  | 
| Jun 2023 | -  | $99.58M(+16.7%)  | $302.95M(+18.1%)  | 
| Mar 2023 | -  | $85.37M(+40.5%)  | $256.48M(+19.7%)  | 
| Dec 2022 | $214.20M(+52.1%)  | $60.76M(+6.1%)  | $214.20M(+11.7%)  | 
| Sep 2022 | -  | $57.24M(+7.8%)  | $191.75M(+12.5%)  | 
| Jun 2022 | -  | $53.11M(+23.3%)  | $170.47M(+10.9%)  | 
| Mar 2022 | -  | $43.09M(+12.5%)  | $153.72M(+9.1%)  | 
| Dec 2021 | $140.83M(+18.3%)  | $38.31M(+6.6%)  | $140.83M(+5.5%)  | 
| Sep 2021 | -  | $35.95M(-1.1%)  | $133.54M(+5.2%)  | 
| Jun 2021 | -  | $36.37M(+20.4%)  | $126.90M(+5.6%)  | 
| Mar 2021 | -  | $30.20M(-2.6%)  | $120.14M(+0.9%)  | 
| Dec 2020 | $119.07M(+16.4%)  | $31.01M(+5.8%)  | $119.07M(+0.8%)  | 
| Sep 2020 | -  | $29.32M(-1.0%)  | $118.18M(-1.3%)  | 
| Jun 2020 | -  | $29.60M(+1.6%)  | $119.76M(+0.6%)  | 
| Mar 2020 | -  | $29.14M(-3.3%)  | $118.99M(+16.3%)  | 
| Dec 2019 | $102.31M(>+9900.0%)  | $30.12M(-2.5%)  | $102.31M(+40.8%)  | 
| Sep 2019 | -  | $30.90M(+7.1%)  | $72.68M(+73.9%)  | 
| Jun 2019 | -  | $28.84M(+131.7%)  | $41.79M(+222.7%)  | 
| Mar 2019 | -  | $12.45M(+2389.7%)  | $12.95M(+2489.7%)  | 
| Dec 2018 | $500.00K(>+9900.0%)  | $500.00K(>+9900.0%)  | $500.00K(>+9900.0%)  | 
| Sep 2018 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Jun 2018 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Mar 2018 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Dec 2017 | $0.00(0.0%)  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Sep 2017 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Jun 2017 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Mar 2017 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Dec 2016 | $0.00(0.0%)  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Sep 2016 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Jun 2016 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Mar 2016 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Dec 2015 | $0.00  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Sep 2015 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Date | Annual | Quarterly | TTM | 
|---|---|---|---|
| Jun 2015 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Mar 2015 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Dec 2014 | $0.00(0.0%)  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Sep 2014 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Jun 2014 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Mar 2014 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Dec 2013 | $0.00(0.0%)  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Sep 2013 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Jun 2013 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Mar 2013 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Dec 2012 | $0.00(0.0%)  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Sep 2012 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Jun 2012 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Mar 2012 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Dec 2011 | $0.00(0.0%)  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Sep 2011 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Jun 2011 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Mar 2011 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Dec 2010 | $0.00(0.0%)  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Sep 2010 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Jun 2010 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Mar 2010 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Dec 2009 | $0.00(0.0%)  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Sep 2009 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Jun 2009 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Mar 2009 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Dec 2008 | $0.00(0.0%)  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Sep 2008 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Jun 2008 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Mar 2008 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Dec 2007 | $0.00(0.0%)  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Sep 2007 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Jun 2007 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Mar 2007 | -  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Dec 2006 | $0.00(0.0%)  | $0.00(0.0%)  | $0.00(0.0%)  | 
| Sep 2006 | -  | $0.00  | $0.00  | 
| Dec 2005 | $0.00(0.0%)  | -  | -  | 
| Dec 2004 | $0.00(0.0%)  | -  | -  | 
| Dec 2003 | $0.00(0.0%)  | -  | -  | 
| Dec 2002 | $0.00  | -  | -  | 
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual revenue?
 - What is the all-time high annual revenue for Catalyst Pharmaceuticals, Inc.?
 - What is Catalyst Pharmaceuticals, Inc. annual revenue year-on-year change?
 - What is Catalyst Pharmaceuticals, Inc. quarterly revenue?
 - What is the all-time high quarterly revenue for Catalyst Pharmaceuticals, Inc.?
 - What is Catalyst Pharmaceuticals, Inc. quarterly revenue year-on-year change?
 - What is Catalyst Pharmaceuticals, Inc. TTM revenue?
 - What is the all-time high TTM revenue for Catalyst Pharmaceuticals, Inc.?
 - What is Catalyst Pharmaceuticals, Inc. TTM revenue year-on-year change?
 
What is Catalyst Pharmaceuticals, Inc. annual revenue?
The current annual revenue of CPRX is $491.73M
What is the all-time high annual revenue for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual revenue is $491.73M
What is Catalyst Pharmaceuticals, Inc. annual revenue year-on-year change?
Over the past year, CPRX annual revenue has changed by +$93.53M (+23.49%)
What is Catalyst Pharmaceuticals, Inc. quarterly revenue?
The current quarterly revenue of CPRX is $146.56M
What is the all-time high quarterly revenue for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly revenue is $146.56M
What is Catalyst Pharmaceuticals, Inc. quarterly revenue year-on-year change?
Over the past year, CPRX quarterly revenue has changed by +$23.85M (+19.44%)
What is Catalyst Pharmaceuticals, Inc. TTM revenue?
The current TTM revenue of CPRX is $558.50M
What is the all-time high TTM revenue for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high TTM revenue is $558.50M
What is Catalyst Pharmaceuticals, Inc. TTM revenue year-on-year change?
Over the past year, CPRX TTM revenue has changed by +$124.02M (+28.55%)